Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × peficitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 1 Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

etrolizumab 4 Infliximab 3 peficitinib 1 golimumab 1 NX-13 1 Methylprednisolone 1 Mesalamine 1 Injections 1 CT-P13 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡